Skip to main content

Grafa News and Videos — Page 1610

Latest

Grafa

Scienture revenue rallies 216% in 2025 on Arbli launch and record margin expansion

Scienture (NASDAQ:SCNX), a specialty pharmaceutical company focused on developing and commercializing innovative therapies for underserved patient populations, today reported its financial results for the full year ended December 31, 2025.

Read more: Scienture revenue rallies 216% in 2025 on Arbli launch and record margin expansion

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift